Skylands Capital’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.5M Sell
191,065
-2,975
-2% -$201K 1.64% 15
2026
Q2
$12.4M Buy
194,040
+32,950
+20% +$2.17M 1.53% 16
2026
Q1
$11.5M Buy
161,090
+35,550
+28% +$2.8M 1.5% 15
2025
Q4
$10.3M Sell
125,540
-18,850
-13% -$1.47M 1.4% 19
2025
Q3
$10.8M Sell
144,390
-9,700
-6% -$723K 1.5% 16
2025
Q2
$11.4M Buy
154,090
+31,925
+26% +$2.22M 1.66% 17
2025
Q1
$9.9M Sell
122,165
-34,625
-22% -$2.98M 1.42% 19
2024
Q4
$12.3M Buy
156,790
+25,815
+20% +$2.19M 1.71% 16
2024
Q3
$12.3M Sell
130,975
-2,550
-2% -$214K 1.67% 17
2024
Q2
$10.4M Buy
133,525
+26,450
+25% +$2.16M 1.47% 16
2024
Q1
$9.7M Sell
107,075
-4,975
-4% -$414K 1.34% 21
2023
Q4
$8.66M Buy
112,050
+20,725
+23% +$1.45M 1.28% 20
2023
Q3
$6.21M Buy
91,325
+78,475
+611% +$5.71M 0.94% 30
2023
Q2
$1.04M Buy
12,850
+6,250
+95% +$499K 0.15% 92
2023
Q1
$541K Sell
6,600
-3,050
-32% -$218K 0.08% 107
2022
Q4
$563K Buy
+9,650
New +$556K 0.09% 107

Other funds holding GEHC

Skylands Capital's GEHC Position: Q3 2026 in Review

Skylands Capital reduced its GE HealthCare (GEHC) stake by 1.5% in Q3 2026, selling an estimated $201K and leaving 191,065 shares worth $12.5M. The position accounts for 1.64% of the portfolio, ranked #15.

Skylands Capital first reported a position in GEHC in Q4 2022 and has held it in 16 quarters since. 287 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • Skylands Capital held 191,065 shares of GE HealthCare worth $12.5M as of Q3 2026.
  • Skylands Capital sold 2,975 GE HealthCare shares in Q3 2026, an estimated $201K.
  • GE HealthCare made up 1.64% of Skylands Capital's portfolio in Q3 2026, its #15 holding.
  • Skylands Capital first reported a position in GE HealthCare in Q4 2022 and has held it in 16 quarters since.
  • 287 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Skylands Capital's 13F filing for Q3 2026, filed 21 Oct 2026.